Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Quanterix Corporation (QTRX)
NASDAQ:QTRX
Quanterix (QTRX) Stock Price & Analysis
262 Followers
QTRX Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$11.83 - $29.70
Previous Close$12.52
Volume246.10K
Average Volume (3M)447.50K
Market Cap
$486.80M
Enterprise Value$225.32M
Total Cash (Recent Filing)$301.92M
Total Debt (Recent Filing)$40.45M
Price to Earnings (P/E)―
Beta1.07
Next Earnings
Aug 06, 2024EPS Estimate
-$0.26Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.96
Shares Outstanding38,270,088
10 Day Avg. Volume722,762
30 Day Avg. Volume447,497
Standard Deviation0.18
R-Squared0.18
Alpha-0.00960
Financial Highlights & Ratios
Price to Book (P/B)1.44
Price to Sales (P/S)15.44
Price to Cash Flow (P/CF)-20.50
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue1.98
Enterprise Value/Gross Profit3.25
Enterprise Value/Ebitda-6.72
Forecast
1Y Price Target
$25.67Price Target Upside105.03% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering4
Quanterix News
PremiumCompany Announcements
Brian Blaser Resigns from Quanterix Board for CEO Role
Bulls Say, Bears Say
Bulls Say
Financial PerformanceThe company posted solid revenue growth driven by consumables revenue, albeit partially offset by a meaningful decline in instruments revenue.
Market OpportunityQTRX shares are currently trading at half the multiple of peers despite similar growth and gross margin outlook and a strong balance sheet—presenting an opportunity in the core business and AD Dx upside in medium to longer term.
Technology And Competitive AdvantageQTRX's Simoa assay demonstrates superior sensitivity compared to Roche's Elecsys, which could maintain its competitive advantage in the market.
Bears Say
Market CompetitionThe Alzheimer's disease diagnostics market is becoming more competitive, potentially affecting the market share of existing players.
Regulatory UncertaintyThere is uncertainty regarding potential patent infringement by Roche on QTRX's technology until FDA validation data is officially presented.
Stock PerformanceShares have dropped significantly, with a decline of -52% since their peak in March.
---
Ownership Overview
29.91% Insiders
25.67% Mutual Funds
43.76% Other Institutional Investors
0.67% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
QTRX FAQ
What was Quanterix Corporation’s price range in the past 12 months?
Quanterix Corporation lowest stock price was $11.83 and its highest was $29.70 in the past 12 months.
What is Quanterix Corporation’s market cap?
Currently, no data Available
When is Quanterix Corporation’s upcoming earnings report date?
Quanterix Corporation’s upcoming earnings report date is Aug 06, 2024 which is in 32 days.
How were Quanterix Corporation’s earnings last quarter?
Quanterix Corporation released its earnings results on May 07, 2024. The company reported -$0.26 earnings per share for the quarter, beating the consensus estimate of -$0.309 by $0.049.
Is Quanterix Corporation overvalued?
According to Wall Street analysts Quanterix Corporation’s price is currently Undervalued.
Does Quanterix Corporation pay dividends?
Quanterix Corporation does not currently pay dividends.
What is Quanterix Corporation’s EPS estimate?
Quanterix Corporation’s EPS estimate is -$0.26.
How many shares outstanding does Quanterix Corporation have?
Quanterix Corporation has 38,270,090 shares outstanding.
What happened to Quanterix Corporation’s price movement after its last earnings report?
Quanterix Corporation reported an EPS of -$0.26 in its last earnings report, beating expectations of -$0.309. Following the earnings report the stock price went down -4.896%.
Which hedge fund is a major shareholder of Quanterix Corporation?
Among the largest hedge funds holding Quanterix Corporation’s share is Gilder Gagnon Howe & Co LLC.. It holds Quanterix Corporation’s shares valued at 28M.
---
Quanterix Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$25.67 (105.03% Upside)
$25.67 (105.03% Upside)
Blogger Sentiment
Bullish
QTRX Sentiment 100%
Sector Average 72%
Sector Average 72%
Hedge Fund Trend
Decreased
By 42.1K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Positive
Last 7 Days ▲ 6.0%
Last 30 Days ▲ 10.6%
Last 30 Days ▲ 10.6%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-42.62%
12-Months-Change
Fundamentals
Return on Equity
-10.39%
Trailing 12-Months
Asset Growth
-3.64%
Trailing 12-Months
Company Description
Quanterix Corporation
Quanterix Corp. is a life sciences company, which develops ultra-sensitive digital immunoassay platform that advances precision health for life sciences research and diagnostics. Its Single Molecule Array (Simoa) technology platform uses single molecule measurements to access previously undetectable proteins. The company was founded by Nicholas J. Naclerio and David R. Walt in April 2007 and is headquartered in Lexington, MA.
---
QTRX Company Deck
---
QTRX Earnings Call
Q1 2024
0:00 / 0:00
---
QTRX Stock 12 Month Forecast
Average Price Target
$25.67
▲(105.03% Upside)
Technical Analysis
Best Analysts Covering QTRX
1 Year
1 Year Success Rate
4/14 ratings generated profit
1 Year Average Return
-22.16%
reiterated a buy rating 24 days ago
Copying Sung Ji Nam's trades and holding each position for 1 Year would result in 28.57% of your transactions generating a profit, with an average return of -22.16% per trade.
---